Intermagnetics income leaps
Increased sales of high-field MR magnets contributed to income growth at Intermagnetics General during the fourth quarter of fiscal 2003. Income rose 27% to $4.4 million from $3.4 million in the previous-year period. Excluding one-time items that
Increased sales of high-field MR magnets contributed to income growth at Intermagnetics General during the fourth quarter of fiscal 2003. Income rose 27% to $4.4 million from $3.4 million in the previous-year period. Excluding one-time items that resulted in a net charge of about $1 million, net income for the fiscal year ended May 25 was $15.9 million. Reported net income was $14.9 million, including one-time charges associated with the sale of securities, which was partially offset by a favorable settlement of long-standing trade litigation. These compare with income of $14.6 million in the previous fiscal year, excluding nonrecurring items that resulted in a net gain of about $6 million. Reported net income for the year ended May 26, 2002, was $20.6 million, including gains from the divestiture of the company's LTS wire and helium gas businesses, which was partially offset by charges related to restructuring of the Instrumentation segment and the write-down of investments. Net sales for the recently completed fiscal year were $147.4 million compared with $144.3 million from ongoing operations the prior year.
MR sales increased revenue to $125.1 million from $120.7 million. Operating profit increased at a higher rate than revenue because of improved product mix, notably among higher field strength 3T and 1.5T magnets. The company predicted continued increases in sales of its recently introduced 3T superconducting MRI magnet. Added revenues could accrue around fiscal 2005 with the commercial delivery of 1T open magnets.
Can MRI-Guided Transurethral Ultrasound Ablation Have an Impact for Localized Prostate Cancer?
December 11th 2023Follow-up MRI imaging one year after transurethral ultrasound ablation revealed approximately 50 percent decreases in prostate volume and median PSA density, according to recently presented research findings at the 2023 Society of Urologic Oncology (SUO) Annual Meeting.
What a New Mammography Study Reveals About BMI, Race, Ethnicity and Advanced Breast Cancer Risk
December 8th 2023In a new study examining population attributable risk proportions (PARPs) based on data from over three million screening mammography exams, researchers found that postmenopausal Black women had the highest BMI-related PARP and premenopausal Asian and Pacific Islander women had the highest breast density-related PARP for advanced breast cancer.
Study: Contrast-Enhanced Mammography Changes Surgical Plan in 22.5 Percent of Breast Cancer Cases
December 7th 2023Contrast-enhanced mammography detected additional lesions in 43 percent of patients and led to additional biopsies in 18.2 percent of patients, over half of whom had malignant lesions, according to a study of over 500 women presented at the recent Radiological Society of North America (RSNA) conference.
What a New Study Reveals About Adjunctive DBT and Early-Stage Invasive Breast Cancer
December 6th 2023The combination of digital breast tomosynthesis (DBT) and digital mammography had a 21.6 higher invasive breast cancer detection rate for stage 1 tumors than digital mammography alone, according to a new study involving nearly 100,000 women.
